These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 3268920)
1. Relation between fasting C-peptide and other clinical and metabolic variables in non-insulin-dependent diabetes mellitus. Seghieri G; Alviggi L; Caselli P; Breschi C; Mammini P; Gironi A; Bartolomei A; De Giorgio LA Quad Sclavo Diagn; 1988; 24(1-4):65-72. PubMed ID: 3268920 [No Abstract] [Full Text] [Related]
2. [C-peptide determination in diabetics for the evaluation of insulin requirements]. Keller U; Pasquel M; Berger W Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060 [TBL] [Abstract][Full Text] [Related]
3. [The effect of age on the response of insulin and C-peptide to oral glucose in non-insulin-dependent diabetes]. Bonora E; Moghetti P; Querena M; Coscelli C; Butturini U; Muggeo M Minerva Endocrinol; 1985; 10(3):165-9. PubMed ID: 3913861 [No Abstract] [Full Text] [Related]
4. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus]. Perusicová J; Bárová H; Hill M; Masek Z Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349 [TBL] [Abstract][Full Text] [Related]
5. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics in the discrimination between patients with low or high C-peptide level among middle-aged insulin-treated diabetics. Laakso M; Sarlund H; Pyörälä K Diabetes Res; 1987 Feb; 4(2):95-9. PubMed ID: 3581663 [TBL] [Abstract][Full Text] [Related]
7. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes. Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461 [TBL] [Abstract][Full Text] [Related]
8. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis. Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127 [TBL] [Abstract][Full Text] [Related]
9. [Clinical value of C-peptide determination]. Meier C; Ladewig A; Keller U; Berger W Praxis (Bern 1994); 1997 Aug; 86(34):1289-95. PubMed ID: 9381016 [TBL] [Abstract][Full Text] [Related]
10. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus. Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025 [TBL] [Abstract][Full Text] [Related]
11. [Long-term course of type I-simulating type II-diabetes mellitus]. Lohmann D; Verlohren HJ; Borsdorf G; Brunner E; Bierwolf B; Richter HV Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):241-4. PubMed ID: 6391902 [TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus]. Kim MG; Choi WC Korean J Hepatol; 2006 Dec; 12(4):524-9. PubMed ID: 17237630 [TBL] [Abstract][Full Text] [Related]
13. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test. Iwasaki Y; Kondo K; Hasegawa H; Oiso Y Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552 [TBL] [Abstract][Full Text] [Related]
14. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance. Levy J; Vandenberg M; Grunberger G Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219 [TBL] [Abstract][Full Text] [Related]
15. [The utility of postprandial C-peptide evaluation in type 2 diabetes]. Prando R; Giusti R; Ciuchi E; Giusto M; Melga PL; Cheli V Riv Eur Sci Med Farmacol; 1996; 18(3):95-104. PubMed ID: 9213846 [TBL] [Abstract][Full Text] [Related]
16. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function]. Li X; Zhou ZG; Qi HY; Chen XY; Huang G Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594 [TBL] [Abstract][Full Text] [Related]
17. Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea. Allen BT; Feinglos MN; Lebovitz HE Arch Intern Med; 1985 Oct; 145(10):1900-3. PubMed ID: 3899039 [No Abstract] [Full Text] [Related]
18. [Clinical characteristics and hormonal-metabolic homeostasis in patients with insulin-dependent diabetes mellitus with stable and labile courses]. Tikhonova EP; Levchenko TP; Pavliuchenko RV; Lavrova EV; Blokhina ZN Ter Arkh; 1984; 56(10):84-6. PubMed ID: 6395423 [TBL] [Abstract][Full Text] [Related]
19. Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem? Rosenbloom AL Pediatr Diabetes; 2007 Apr; 8(2):51-2. PubMed ID: 17448126 [No Abstract] [Full Text] [Related]
20. [Significance of the determination of C-peptide in type 2 diabetes]. Perusicová J; Skachová J Vnitr Lek; 1987 Feb; 33(2):134-9. PubMed ID: 3548038 [No Abstract] [Full Text] [Related] [Next] [New Search]